$RYTM
Rhythm Pharmaceuticals, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$91.97
▼-0.23%-$0.210
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateRhythm Pharmaceuticals, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is RYTM down today? It is at $91.97 (-0.23%), and our scanner flagged it 87 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment RYTM spikes, and full due diligence on RYTM — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $RYTM 87 times in the last 30 days. Create a free account to track $RYTM, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
RYTM is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 2 unusual-volume and momentum alerts on RYTM today, peaking at 2.6x its normal volume. A recent catalyst in the news: “Rhythm Pharmaceuticals, Inc. (RYTM) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release.” Early read: bullish.
Likely catalystRHYTHM PHARMACEUTICALS, INC.: Q2 FY2026 results, three months to Jun 30, 2026, from an SEC filing. Read it →Latest filingSC 13GPassive 5%+ stake disclosedOct 13, 2026 · 15 days agoSources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Meeker David P Officer | Sold (automatic/other) | -50K 0.07% of company | sold 17% | 239K | $5.1M at $101.75 | Sep 14, 26 |
Meeker David P Officer | Other | 50K 0.07% of company | added 21% | 289K | $303K at $6.05 | Sep 14, 26 |
Smith Hunter C Officer | Sold (automatic/other) | -63K 0.09% of company | sold 36% | 114K | $6.6M at $104.59 | Aug 31, 26 |
Smith Hunter C Officer | Other | 57K 0.08% of company | added 48% | 177K | $1.5M at $25.79 | Aug 31, 26 |
Lee Jennifer Kayden Officer | Sold (automatic/other) | -76K 0.1% of company | n/a | n/a | $8.9M at $117.38 | Aug 13, 26 |
Lee Jennifer Kayden Officer | Other | 57K 0.08% of company | added 100% | 76K | $385K at $6.80 | Aug 13, 26 |
Garfield Alastair Officer | Sold (automatic/other) | -8K 0.01% of company | sold 77% | 2K | $901K at $116.11 | Aug 13, 26 |
Shulman Joseph Officer | Sold (automatic/other) | -5K | sold 24% | 16K | $608K at $119.75 | Aug 13, 26 |
Shulman Joseph Officer | Other | 2K | added 11% | 21K | $14K at $6.80 | Aug 13, 26 |
Mazabraud Yann Officer | Sold (automatic/other) | -57K 0.08% of company | sold 51% | 56K | $6.4M at $111.80 | Aug 12, 26 |
Mazabraud Yann Officer | Other | 47K 0.07% of company | added 71% | 113K | $317K at $6.80 | Aug 12, 26 |
Garfield Alastair Officer | Sold (automatic/other) | -2K | sold 18% | 10K | $237K at $110.41 | Jul 1, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
RYTM is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 2 unusual-volume and momentum alerts on RYTM today, peaking at 2.6x its normal volume. A recent catalyst in the news: “Rhythm Pharmaceuticals, Inc. (RYTM) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release.” Early read: bullish.
RYTM last traded at $91.97, down 0.23% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Rhythm Pharmaceuticals, Inc. Common Stock (RYTM) is next expected to report earnings on Tuesday, November 3, 2026 (before open), about 6 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The RYTM Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged RYTM 87 times in the last 30 days.
RYTM (Rhythm Pharmaceuticals, Inc. Common Stock) trades on XNAS, with a market cap of about $6.35B in the PHARMACEUTICAL PREPARATIONS sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge RYTM for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$RYTM discussion
Sign in to ask a question or join the discussion.